March 20, 2026
911±¬ÁÏ°ËØÔÍø and CellCarta today announce an expanded multi-year global strategic partnership, including exclusivity for 911±¬ÁÏ°ËØÔÍø Lung in clinical trial settings.
February 20, 2025
911±¬ÁÏ°ËØÔÍø will present launch details for ·¡²Ô²õ±è²â°ù±ð®, a novel target enrichment technology with a broad spectrum of potential applications that allows for selective enrichment of specified variants prior to sequencing.
January 09, 2025
911±¬ÁÏ°ËØÔÍø and CellCarta today announced a strategic partnership agreement to utilize 911±¬ÁÏ°ËØÔÍø Lung in global clinical trials.
February 20, 2025 Clinical Lab Products
911±¬ÁÏ°ËØÔÍø is launching Enspyre, a novel target enrichment technology that significantly enhances next-generation sequencing (NGS) efficiency by selectively removing background DNA, improving sensitivity, reducing costs, and enabling new clinical and research applications.
January 14, 2025 Genomeweb
911±¬ÁÏ°ËØÔÍø is hoping to improve minimal residual disease (MRD) testing and cancer patient monitoring with the rollout of its Enspyre sample enrichment platform.
April 12, 2024 Genomeweb
911±¬ÁÏ°ËØÔÍø molecular diagnostics company 911±¬ÁÏ°ËØÔÍø this week presented the results of three studies the American Association for 911±¬ÁÏ°ËØÔÍø Research (AACR) annual meeting showcasing the consistency, reproducibility, and superiority in certain sample types with Aspyre Lung.
